PASG - Passage BIO, Inc.

QQQ $ 468.28 $ 9.96 (2.17 %)

DIA $ 409.73 $ 1.01 (0.25 %)

SPY $ 554.79 $ 5.63 (1.03 %)

TLT $ 100.61 $ -0.08 (-0.08 %)

GLD $ 232.25 $ -0.37 (-0.16 %)

Previous Close

$ 0.766

Open

Bid

$ 0.64 x 200

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 0.58 - $ 1.79

Volume

194,793

Average Volume

Market Cap

47.31M

Beta (5Y Monthly)

$ 1.51

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-30-2024	10-Q
2	05-14-2024	03-31-2024	10-Q
3	03-04-2024	12-31-2023	10-K
4	11-13-2023	09-30-2023	10-Q
5	08-07-2023	06-30-2023	10-Q
6	05-11-2023	03-31-2023	10-Q
7	03-06-2023	12-31-2022	10-K
8	11-10-2022	09-30-2022	10-Q
9	08-04-2022	06-30-2022	10-Q
10	05-16-2022	03-31-2022	10-Q
11	03-03-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-05-2021	06-30-2021	10-Q
14	05-05-2021	03-31-2021	10-Q
15	03-03-2021	12-31-2020	10-K
16	11-10-2020	09-30-2020	10-Q
17	08-13-2020	06-30-2020	10-Q
18	05-11-2020	03-31-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Passage Bio shares are trading higher afte...
09/03/2024 12:24:48

Rodman & Renshaw Initiates Coverage On Pas...
09/03/2024 12:07:09

Rodman & Renshaw initiates coverage on Passage Bio (NASDAQ:PASG) with a Buy rating and announces Price Target of $7.

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
09/02/2024 20:31:10

Passage Bio Announced Out-Licensing of Thr...
08/01/2024 11:13:50

Passage Bio, Inc. (NASDAQ:PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neu...

Passage Bio Receives Positive Feedback Fro...
07/16/2024 11:11:36

Canaccord Genuity Maintains Buy on Passage...
05/15/2024 13:34:25

Canaccord Genuity analyst Whitney Ijem maintains Passage Bio (NASDAQ:PASG) with a Buy and lowers the price target from $14 t...

Canaccord Genuity Reiterates Buy on Passag...
03/05/2024 14:03:18

Canaccord Genuity analyst Whitney Ijem reiterates Passage Bio (NASDAQ:PASG) with a Buy and maintains $14 price target.

Passage Bio Tapped Kathleen Borthwick as C...
03/04/2024 12:07:57

Appointed Kathleen Borthwick as Chief Financial Officer, effective March 1, 2024: Ms. Borthwick previously served as the comp...

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
01/26/2024 13:05:58

12 Health Care Stocks Moving In Monday's A...
01/22/2024 21:31:12

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
01/17/2024 21:31:08

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
12/21/2023 13:07:41

Why BlackBerry Shares Are Trading Lower By...
12/21/2023 12:46:57

Shares of BlackBerry Limited (NYSE: BB) moved lower in pre-market trading following the release of third-quarter results.

neurology-focused-passage-bio-reveals-initial-data-from-dementia-study-outlines-strategic-priorities

Neurology-Focused Passage Bio Reveals Init...
12/20/2023 15:57:49

Passage Bio Inc (NASDAQ: PASG) announced initial safety and biomarker data from three Cohort 1 patients in the ongoing global P...

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
12/20/2023 13:07:08

Passage Bio Announced Initial Safety And B...
12/20/2023 12:05:24

Monday.Com To Rally Around 20%? Here Are 1...
11/14/2023 12:38:21

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

Raymond James Maintains Outperform on Pass...
11/14/2023 08:47:08

Raymond James analyst Danielle Brill maintains Passage Bio (NASDAQ:PASG) with a Outperform and lowers the price target from ...

Passage Bio Q3 EPS $(0.49) Misses $(0.46) ...
11/13/2023 13:07:07

Passage Bio (NASDAQ:PASG) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.46)...

Recap: Passage Bio Q3 Earnings
11/13/2023 12:15:10